JAMP ABACAVIR / LAMIVUDINE
Identification of Jamp Abacavir / Lamivudine
| No description |
Google image searchProduct monograph
Active ingredients
abacavir (abacavir sulfate), 600 MG
lamivudine, 300 MG
DIN: 02497654
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 22-FEB-2022
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR02 — LAMIVUDINE AND ABACAVIR (ATC/DDD)
Reference brand drug: Kivexa
